Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Bovine Fibronectin Type III Domain Containing 5 (FNDC5)

Cat. No.AP9C227

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Bovine Fibronectin Type III Domain Containing 5 (FNDC5) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 27.5 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Bovine
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 27.5 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.

Target Information

Bovine fibronectin type III domain containing 5 (FNDC5) is a protein found in cattle that is part of the family of proteins containing fibronectin type III (FnIII) domains. FNDC5 is known for its role in muscle metabolism and is the precursor to irisin, a hormone that is thought to be involved in the regulation of energy expenditure and thermogenesis. In Bovines, FNDC5 may play a role in the adaptation to physical activity and cold exposure, contributing to the overall metabolic health and possibly influencing the efficiency of muscle function and fat metabolism in cattle.

Protein Bovine Fibronectin Type III Domain Containing 5 (FNDC5)
Gene ID 538905
UniProt ID A0A3Q1MMB3

Shipping and Storage

This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months. Avoid repeated freezing and thawing.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in sterile distilled water to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket